The influence of the peptide NAP on Mac-1-deficient mice following closed head injury.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Peptides

• Publication date

  2005-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.PEPTIDES.2005.03.014PMID 16042992
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Brain injury-dependent expression of activity-dependent neuroprotective protein

  2007cited by this paper
• Activity-dependent neurotrophic factor-9 and NAP promote neurite outgrowth in rat hippocampal and cortical cultures

  2007cited by this paper
• The expression of activity-dependent neuroprotective protein (ADNP) is regulated by brain damage and treatment of mice with the ADNP derived peptide, NAP, reduces the severity of traumatic head injury.

  2005cited by this paper
• Subcellular localization and secretion of activity-dependent neuroprotective protein in astrocytes.

  2004cited by this paper
• Association between Intravascular Microthrombosis and Cerebral Ischemia in Traumatic Brain Injury

  2004cited by this paper
• PKC signaling mediates global enhancement of excitatory synaptogenesis in neurons triggered by local contact with astrocytes.

  2004cited by this paper
• Wound Healing Complications in Closed and Open Calcaneal Fractures

  2004cited by this paper
• Melatonin‐induced neuroprotection after closed head injury is associated with increased brain antioxidants and attenuated late‐phase activation of NF‐κB and AP‐1

  2004cited by this paper
• A Femtomolar Acting Octapeptide Interacts with Tubulin and Protects Astrocytes against Zinc Intoxication*

  2004cited by this paper
• Astrocytes and Brain Injury

  2003cited by this paper
• Vasoactive intestinal peptide prevents activated microglia‐induced neurodegeneration under inflammatory conditions: potential therapeutic role in brain trauma

  2003cited by this paper
• Injections of the neuroprotective peptide NAP to newborn mice attenuate head-injury-related dysfunction in adults

  2003cited by this paper
• Therapeutic Vaccination for Closed Head Injury

  2003cited by this paper
• Activity-dependent neuroprotective protein: a novel gene essential for brain formation.

  2003cited by this paper
• Time course of cellular pathology after controlled cortical impact injury.

  2003cited by this paper
• Detrimental and beneficial effects of injury-induced inflammation and cytokine expression in the nervous system.

  2002cited by this paper
• NAP, a Femtomolar-Acting Peptide, Protects the Brain Against Ischemic Injury by Reducing Apoptotic Death

  2002cited by this paper
• Intravascular coagulation: a major secondary insult in nonfatal traumatic brain injury.

  2002cited by this paper
• Inflammatory response in acute traumatic brain injury: a double-edged sword

  2002cited by this paper
• A single administration of the peptide NAP induces long-term protective changes against the consequences of head injury

  2002cited by this paper
• Down-regulation of complement receptor 3 and major histocompatibility complex I and II antigen-like immunoreactivity accompanies ramification in isolated rat microglia.

  2002cited by this paper
• An endogenous cannabinoid (2-AG) is neuroprotective after brain injury

  2001cited by this paper
• Recognition of Fibrinogen by Leukocyte Integrins

  2001cited by this paper
• Cloning and Characterization of the Human Activity-dependent Neuroprotective Protein*

  2001cited by this paper
• Mac-1 (CD11b/CD18) is essential for Fc receptor-mediated neutrophil cytotoxicity and immunologic synapse formation.

  2001cited by this paper
• Control of glial immune function by neurons

  2001cited by this paper
• A peptide derived from activity-dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice.

  2001cited by this paper
• Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases

  2001cited by this paper
• Astrocytic factors down-regulate the expression of major histocompatibility complex-class-II and intercellular adhesion molecule-1 on human monocytes.

  2001cited by this paper
• Prevention of fetal demise and growth restriction in a mouse model of fetal alcohol syndrome.

  2001cited by this paper
• Modulation (inhibition and augmentation) of complement receptor-3-mediated myelin phagocytosis.

  2001cited by this paper
• Neuroprotective peptide drug delivery and development: potential new therapeutics.

  2001cited by this paper
• Effect of Integrin β2 Subunit Truncations on LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18) Assembly, Surface Expression, and Function1

  2000cited by this paper
• Rapid and Widespread Microglial Activation Induced by Traumatic Brain Injury in Rat Brain Slices

  2000cited by this paper
• Protective peptides derived from novel glial proteins.

  2000cited by this paper
• Effect of integrin beta 2 subunit truncations on LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18) assembly, surface expression, and function.

  2000cited by this paper
• A novel peptide prevents death in enriched neuronal cultures.

  2000cited by this paper
• Strongly compromised inflammatory response to brain injury in interleukin‐6‐deficient mice

  1999cited by this paper
• Complete Sequence of a Novel Protein Containing a Femtomolar‐Activity‐Dependent Neuroprotective Peptide

  1999cited by this paper
• Mice deficient in Mac-1 (CD11b/CD18) are less susceptible to cerebral ischemia/reperfusion injury.

  1999cited by this paper
• Long-term intracerebral inflammatory response after experimental focal brain injury in rat.

  1999cited by this paper
• Microglia as mediators of inflammatory and degenerative diseases.

  1999cited by this paper
• Contribution of CR3 to nitric oxide production from macrophages stimulated with high-dose of LPS.

  1998cited by this paper
• Mac-1 (CD11b/CD18) is an oligodeoxynucleotide-binding protein

  1997cited by this paper
• Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant.

  1997cited by this paper
• 1216 Microglial NO induces delayed neuronal death following acute injury in the striatum

  1997cited by this paper
• Macrophage phagocytosis of myelin in vitro determined by flow cytometry: phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-alpha and nitric oxide.

  1996cited by this paper
• The transition of microglia to a ramified phenotype is associated with the formation of stable acetylated and detyrosinated microtubules

  1996cited by this paper
• A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation.

  1996cited by this paper
• An Experimental Model of Closed Head Injury in Mice: Pathophysiology, Histopathology, and Cognitive Deficits

  1996cited by this paper
• Group B streptococcus-induced nitric oxide production in murine macrophages is CR3 (CD11b/CD18) dependent

  1994cited by this paper
• Coupling of the adhesive receptor CD11b/CD18 to functional enhancement of effector macrophage tissue factor response.

  1991cited by this paper
• Mac-1 (CD11b/CD18) mediates adherence-dependent hydrogen peroxide production by human and canine neutrophils.

  1990cited by this paper
• Impaired transendothelial migration by neonatal neutrophils: abnormalities of Mac-1 (CD11b/CD18)-dependent adherence reactions.

  1990cited by this paper
• ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18)

  1990cited by this paper
• Early Polymorphonuclear Leukocyte Accumulation Correlates with the Development of Posttraumatic Cerebral Edema in Rats

  1990cited by this paper
• MAC-1 mediates adherence of human monocytes to endothelium via a protein kinase C dependent mechanism.

  1990cited by this paper
• Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro.

  1989cited by this paper
• Oligospecificity of the cellular adhesion receptor Mac-1 encompasses an inducible recognition specificity for fibrinogen

  1988cited by this paper
• Adhesive receptor Mac-1 coordinates the activation of factor X on stimulated cells of monocytic and myeloid differentiation: an alternative initiation of the coagulation protease cascade.

  1988cited by this paper

• NAP (Davunetide): The Neuroprotective ADNP Drug Candidate Penetrates Cell Nuclei Explaining Pleiotropic Mechanisms

  2023cites this paper
• Activity-Dependent Neuroprotective Protein (ADNP): An Overview of Its Role in the Eye

  2022cites this paper
• PACAP and NAP: Effect of Two Functionally Related Peptides in Diabetic Retinopathy

  2021cites this paper
• The Interaction of Possible Anti-AD ASA-NAP Peptide Conjugate with Tubulin: A Theoretical and Experimental Insight

  2021cites this paper
• A Systematic Review of Closed Head Injury Models of Mild Traumatic Brain Injury in Mice and Rats

  2019cites this paper
• The octapetide NAP alleviates intestinal and extra‐intestinal anti‐inflammatory sequelae of acute experimental colitis

  2018cites this paper
• Davunetide: Peptide therapeutic in neurological disorders.

  2014cites this paper
• Davunetide (NAP) Protects the Retina Against Early Diabetic Injury by Reducing Apoptotic Death

  2014cites this paper
• A Double-Blind, Placebo-Controlled, Ascending-Dose, Randomized Study to Evaluate the Safety, Tolerability and Effects on Cognition of AL-108 after 12 Weeks of Intranasal Administration in Subjects with Mild Cognitive Impairment

  2013cites this paper
• NAP (davunetide) provides functional and structural neuroprotection.

  2011cites this paper
• Activity-Dependent Neuroprotective Protein Modulates Its Own Gene Expression

  2011cites this paper
• Activity-Dependent Neuroprotective Protein (ADNP) Expression in the Amyloid Precursor Protein/Presenilin 1 Mouse Model of Alzheimer’s Disease

  2010cites this paper
• NAP protects against cytochrome c release: inhibition of the initiation of apoptosis.

  2009cites this paper
• Neuroprotection Against Neurodegenerative Diseases: Development of a Novel Hybrid Neuroprotective Peptide Colivelin

  2008cites this paper
• Regulation of activity-dependent neuroprotective protein (ADNP) by the NO-cGMP pathway in the hippocampus during kainic acid-induced seizure.

  2008cites this paper
• The neuropeptide NAP provides neuroprotection against retinal ganglion cell damage after retinal ischemia and optic nerve crush

  2008cites this paper
• Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease

  2008cites this paper
• Nitric Oxide-NGF Mediated PPTA/SP, ADNP, and VIP Expression in the Peripheral Nervous System

  2007cites this paper
• Activity-dependent neuroprotective protein: from gene to drug candidate.

  2007cites this paper
• Blockage of VIP during mouse embryogenesis modifies adult behavior and results in permanent changes in brain chemistry

  2007cites this paper
• From Concept to Potential Therapeutics: Neuroprotective Peptides

  2007cites this paper
• Neuroprotection against neurodegenerative diseases

  2007cites this paper
• NAP: research and development of a peptide derived from activity-dependent neuroprotective protein (ADNP).

  2006cites this paper
• Recombinant activity-dependent neuroprotective protein protects cells against oxidative stress.

  2006cites this paper
• Therapeutic Vaccination for Closed Head Injury

  2003cites this paper